Ulysses Management’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Ulysses Management’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,000	Closed	-$1.21K	–	63
2024 Q4	$1.21K	Sell	11,000 -11,187	-50%	-$903	﹤0.01%	52
2024 Q3	$892	Hold	22,187	–	–	﹤0.01%	51
2024 Q2	$1.44K	Hold	22,187	–	–	﹤0.01%	56
2024 Q1	$998	Hold	22,187	–	–	﹤0.01%	54
2023 Q4	$666	Hold	22,187	–	–	﹤0.01%	51
2023 Q3	$1.55K	Hold	22,187	–	–	﹤0.01%	43
2023 Q2	$2.22K	Hold	22,187	–	–	﹤0.01%	48
2023 Q1	$2.22K	Hold	22,187	–	–	﹤0.01%	49
2022 Q4	$8.88K	Sell	22,187 -3,030	-12%	-$1.33K	﹤0.01%	40
2022 Q3	$12K	Hold	25,217	–	–	﹤0.01%	46
2022 Q2	$6K	Hold	25,217	–	–	﹤0.01%	52
2022 Q1	$25K	Hold	25,217	–	–	﹤0.01%	53
2021 Q4	$28K	Buy	+25,217	New	+$31.4K	﹤0.01%	54

Other funds holding CTV.WS

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Ulysses Management's CTV.WS Position: Q1 2025 in Review

Ulysses Management sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 11,000 shares — an estimated $1.21K sold.

Ulysses Management first reported a position in CTV.WS in Q4 2021 and held it in 13 quarters. The position peaked at $28K in Q4 2021. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

Ulysses Management reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
Ulysses Management sold 11,000 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $1.21K.
Ulysses Management first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 13 quarters.
Ulysses Management's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $28K in Q4 2021.
1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on Ulysses Management's 13F filing for Q1 2025, filed 15 May 2025.